We found that Sirolimus in vitro it was not only effective in the treatment of neurasthenia, but also improved and eliminated the symptoms of FD. Since then, we gave flupentixol and melitracen to patients with FD accompanied by vexation, irritability and other emotional abnormalities, with very high efficacy achieved.
Finally, we also gave flupentixol and melitracen to patients with FD not accompanied by insomnia or emotional abnormalities, with effective rate of about 80%. Because of the above experience, we extended the use of flupentixol and melitracen to the treatment of functional diseases, such as gastroesophageal reflux disease (GERD) and functional abdominal pain, and organic diseases, such as peptic
ulcer and jaundice which is mainly manifested in increased indirect bilirubin, also with amazing therapeutic effects. How flupentixol and melitracen works for such dieases has aroused our consideration. From a pharmacological point of view, it is used for the treatment of mild to moderate anxiety and depression, both of which are mostly psychological phenomena, essentially resulting from psychological activity. Therefore, we believe that its Target Selective Inhibitor Library therapeutic mechanism is to change the psychological activity by regulating the neurotransmitters. Then, there are two explanations for the mechanism of its improvement of digestive symptoms. First, the digestive symptoms are caused by anxiety and depression. This is difficult to understand, because psychiatric symptoms are not the cause and it can not cause other symptoms. Besides, in many FD patients without anxiety or depression, the symptoms were also improved by administration of this drug, indicating that it improves the psychological
activity via neurotransmitters, and thus achieves a clinical effect. Second, like psychiatric symptoms, the digestive symptoms are psychological phenomena in essence. This can explain why the drug can treat patients with FD not accompanied by psychiatric symptoms. In summary, if the majority of the symptoms of FD are psychological phenomena, a Etofibrate new theoretical system, that is, the “general medical psychology” system must be built. Medical psychology is a science that studies psychological activities through psychological phenomena, such as emotion, cognition and behavior, mainly by psychiatrist and psychologists. General medical psychology holds that some clinical symptoms and phenomena in the systems of human body, such as diarrhea, desire to defecate, chest oppression, shortness of breath, high blood pressure and high blood sugar are also psychological phenomena, and they are mainly studied by non-psychiatrist and non-psychologist. Once the “general medical psychology” system is established, “psychological” is no longer synonymous with “mental”.